Use of high-performance liquid chromatography to monitor stability of tetracycline and chlortetracycline in susceptibility determinations.

Por Ray, A, Newton, V
Publicado em 1991

Waardenburg syndrome.

Por Read, A P, Newton, V E
Publicado em 1997

Hearing aid prescription in general practice.

Por Newton, V E, Stephens, S D, Hillier, V F
Publicado em 1991

Fluorescence Quenching of Carbonyl-Twisted 5-Acyl-1-dimethylaminonaphthalenes by Alcohols

Por Anderson, Rachel S., Nagirimadugu, Newton V., Abelt, Christopher J.
Publicado no ACS Omega (2019)

Relation between postoperative antithrombin III concentrations and site of operation.

Por Gray, S P, Billings, J A, Newton, V, Olive, A
Publicado em 1981

Noise levels within the ear and post-nasal space in neonates in intensive care

Por Surenthiran, S, Wilbraham, K, May, J, Chant, T, Emmerson, A, Newton, V
Publicado em 2003

Assignment of the locus for Waardenburg syndrome type I to human chromosome 2q37 and possible homology to the Splotch mouse.

Por Foy, C, Newton, V, Wellesley, D, Harris, R, Read, A P
Publicado em 1990

Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment

Por Hutchin, T, Thompson, K, Parker, M, Newton, V, Bitner-Glindzicz, M, Mueller, R
Publicado em 2001

National profile of foot orthotic provision in the United Kingdom, part 1: practitioners and scope of practice

Por Nester, CJ, Graham, A, Martinez-Santos, A, Williams, AE, McAdam, J, Newton, V
Publicado no J Foot Ankle Res (2017)

A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling.

Por Evans, D G, Huson, S M, Donnai, D, Neary, W, Blair, V, Newton, V, Strachan, T, Harris, R
Publicado em 1992

Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2)

Por EVANS, D, NEWTON, V, NEARY, W, BASER, M, WALLACE, A, MACLEOD, R, JENKINS, J, GILLESPIE, J, RAMSDEN, R
Publicado em 2000

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.

Por Evans, D G, Huson, S M, Donnai, D, Neary, W, Blair, V, Teare, D, Newton, V, Strachan, T, Ramsden, R, Harris, R
Publicado em 1992

National profile of foot orthotic provision in the United Kingdom, part 2: podiatrist, orthotist and physiotherapy practices

Por Nester, C. J., Graham, A., Martinez-Santos, A., Williams, A. E., McAdam, J., Newton, V., Sweeney, D., Walker, D.
Publicado no J Foot Ankle Res (2018)

Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome.

Por Liu, X Z, Hope, C, Walsh, J, Newton, V, Ke, X M, Liang, C Y, Xu, L R, Zhou, J M, Trump, D, Steel, K P, Bundey, S, Brown, S D
Publicado em 1998

Matrix Assisted Laser Desorption Ionization-Time-of-Flight mass spectrometry identification of Mycobacterium bovis in Bovinae

Por BACANELLI, Gisele, OLARTE, Larissa C., SILVA, Márcio R., RODRIGUES, Rudielle A., CARNEIRO, Paulo A.M., KANEENE, John B., PASQUATTI, Taynara N., TAKATANI, Haruo, ZUMÁRRAGA, Martin J., ETGES, Rodrigo N., ARAÚJO, Flábio R., VERBISCK, Newton V.
Publicado no J Vet Med Sci (2019)

A new locus for non-syndromal, autosomal recessive, sensorineural hearing loss (DFNB16) maps to human chromosome 15q21-q22.

Por Campbell, D A, McHale, D P, Brown, K A, Moynihan, L M, Houseman, M, Karbani, G, Parry, G, Janjua, A H, Newton, V, al-Gazali, L, Markham, A F, Lench, N J, Mueller, R F
Publicado em 1997